申请人:Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
公开号:US05114966A1
公开(公告)日:1992-05-19
The herein-described invention concerns new 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(RS)-substituted, the synthesis procedure and the relative therapeutic use as antioxidizing and radical-scavenging pharmaceuticals with mucoregulation and anti-ischemic properties.
New 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(RS)-substitutes, useful as antioxidizing pharmaceutical products having mucoregolating and anti-ischemic properties
申请人:BIOMEDICA FOSCAMA INDUSTRIA
CHIMICO-FARMACEUTICA S.P.A.
公开号:EP0413668B1
公开(公告)日:1995-12-06
US5114966A
申请人:——
公开号:US5114966A
公开(公告)日:1992-05-19
Synthesis of novel 2-substituted-5-oxycoumarans<i>via</i>A direct route to 2,3-dihydro-5-hydroxy-2-benzofuranacetic acids
作者:Stefano Ceccarelli、Patrizia De Vellis、Romolo Scuri、Sergio Zanarella、Mario Brufani
DOI:10.1002/jhet.5570300318
日期:1993.5
A number of novel 2-substituted 2,3-dihydro-5-benzofuranols optionally protected on 5-OH group have been prepared via a simple two step route to racemic 2,3-dihydro-5-hydroxy-2-benzofuranaceticacids from hydroquinones and 4-bromocrotonates.